Clinical Trial Details
| Trial ID: | L4275 |
| Source ID: | NCT00458016 |
| Associated Drug: | Mb07803 |
| Title: | Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: MB07803|DRUG: Placebo |
| Outcome Measures: | Primary: Fasting Plasma Glucose Concentration, Change from baseline to Day 28 | Secondary: Fasting serum triglycerides and free fatty acids, fasting serum insulin., Change from baseline to Day 28 |
| Sponsor/Collaborators: | Sponsor: Ligand Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 105 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2007-03 |
| Completion Date: | 2008-03 |
| Results First Posted: | |
| Last Update Posted: | 2011-10-03 |
| Locations: | Los Angeles, California, 90057, United States|Walnut Creek, California, 94598, United States|Miami Gardens, Florida, 33169, United States|Miami, Florida, 33169, United States|Chicago, Illinois, 60607, United States|Chicago, Illinois, 60611, United States|Indianapolis, Indiana, 46254, United States|Indianapolis, Indiana, 46260, United States|Butte, Montana, 59701, United States|Las Vegas, Nevada, 89123, United States|Charlotte, North Carolina, 28209, United States|Statesville, North Carolina, 28677, United States|Winston- Salem, North Carolina, 27103, United States|Cincinnati, Ohio, 45246, United States|Delaware, Ohio, 43015, United States|Marion, Ohio, 43302, United States|Willoughby Hills, Ohio, 44094, United States|Tulsa, Oklahoma, 74104, United States|Charleston, South Carolina, 29407, United States|Bristol, Tennessee, 37620, United States|Corpus Christi, Texas, 78404, United States|Dallas, Texas, 75231, United States|Houston, Texas, 77030, United States|San Antonio, Texas, 78229, United States|Richmond, Virginia, 23249, United States |
| URL: | https://clinicaltrials.gov/show/NCT00458016 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|